{"transactions":[{"id":778203,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":1108,"price":33.38,"value":36985.04,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Represents sales of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778202,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":300,"price":32.2467,"value":9674.01,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents VWAP of sales of 300 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $32.0625 to $32.615."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778201,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":4423,"price":31.3843,"value":138812.7589,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents VWAP of sales of 4,423 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $30.9852 to $31.813."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778200,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":205,"price":29.7146,"value":6091.493,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents VWAP of sales of 205 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $29.695 to $30.50."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778199,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"sale","planned":false,"acquired":false,"shares":2115,"price":28.9417,"value":61211.6955,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents VWAP of sales of 2,115 shares of the Company's Common Stock on April 7, 2026 at prices ranging from $28.5071 to $29.3167."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778198,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-07","kind":"purchase","planned":false,"acquired":true,"shares":1108,"price":33.38,"value":36985.04,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents VWAP of purchases of 1,108 shares of the Company's Common Stock on April 7, 2026 at $33.38 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":133986,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778197,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-06","kind":"sale","planned":false,"acquired":false,"shares":45,"price":31.9628,"value":1438.326,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents VWAP of sales of 45 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $31.80 to $32.17."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":141029,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778196,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-06","kind":"sale","planned":false,"acquired":false,"shares":1214,"price":31.0227,"value":37661.5578,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents VWAP of sales of 1,214 shares of the Company's Common Stock on April 6, 2026 at prices ranging from $30.64 to $31.345."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":141029,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778195,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-06","kind":"purchase","planned":false,"acquired":true,"shares":1104,"price":31.02,"value":34246.08,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents purchases of 1,104 shares of the Company's Common Stock on April 6, 2026 at $31.02 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":141029,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778194,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":1134,"price":34.8007,"value":39463.9938,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents VWAP of sales of 1,134 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $34.40 to $35.25."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778193,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":374,"price":33.347,"value":12471.778,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents VWAP of sales of 374 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.23 to $33.45."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778192,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":1794,"price":32.6041,"value":58491.7554,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents VWAP of sales of 1,794 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $32.22 to $33.1251."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778191,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":1265,"price":31.751,"value":40165.015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents VWAP of sales of 1,265 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $31.21 to $32.15."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778190,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"sale","planned":false,"acquired":false,"shares":3099,"price":30.8638,"value":95646.9162,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents VWAP of sales of 3,099 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $30.1332 to $31.1212."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778189,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":701,"price":35.5472,"value":24918.5872,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents VWAP of purchases of 701 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $35.4481 to $35.91."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778188,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":1276,"price":34.7524,"value":44344.0624,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents VWAP of purchases of 1,276 shares of the Company's Common Stock on April 2, 2026 at prices ranging from $33.97 to $34.90."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778187,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:24:06.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":26,"price":33.4704,"value":870.2304,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price (\"VWAP\") of purchases of 26 shares of common stock (\"Common Stock\"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the \"Company\") on April 2, 2026 at prices ranging from $32.90 to $33.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":144974,"source":{"system":"sec-edgar","filing":"0001104659-26-062608","document":"tm2614687-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062608/tm2614687-4_4seq1.xml","form_type":"4"}},{"id":778220,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":46,"price":34.7464,"value":1598.3344,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Represents VWAP of sales of 46 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $34.5271 to $35.3850."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778219,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"sale","planned":false,"acquired":false,"shares":1104,"price":31.52,"value":34798.08,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents sales of 1,104 shares of the Company's Common Stock on April 1, 2026 at $31.52 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778218,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":3401,"price":35.4554,"value":120583.8154,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents VWAP of purchases of 3,401 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $35.06 to $35.90."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778217,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":1613,"price":34.5863,"value":55787.7019,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents VWAP of purchases of 1,613 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $34.04 to $34.98."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778216,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-04-01","kind":"purchase","planned":false,"acquired":true,"shares":1161,"price":31.5309,"value":36607.3749,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents VWAP of purchases of 1,161 shares of the Company's Common Stock on April 1, 2026 at prices ranging from $31.52 to $32.50."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":147731,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778215,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":87,"price":31.52,"value":2742.24,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents sales of 87 shares of the Company's Common Stock on March 31, 2026 at $31.52 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778214,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":5,"price":28.405,"value":142.025,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents sales of 5 shares of the Company's Common Stock on March 31, 2026 at $28.4050 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778213,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":57,"price":27.1147,"value":1545.5379,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents sales of 57 shares of the Company's Common Stock on March 31, 2026 at $27.1147 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778212,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":1251,"price":25.1676,"value":31484.6676,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents VWAP of sales of 1,251 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $25.13 to $25.45."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778211,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":191,"price":24.2843,"value":4638.3013,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents VWAP of sales of 191 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $23.91 to $24.6089."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778210,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":411,"price":32.5962,"value":13397.0382,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents VWAP of purchases of 411 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $32.4343 to $32.91."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778209,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1957,"price":31.4512,"value":61549.9984,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents VWAP of purchases of 1,957 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $31.215 to $31.17."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778208,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":186,"price":30.4754,"value":5668.4244,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents VWAP of purchases of 186 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $30.1693 to $30.73."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778207,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":17,"price":27.7838,"value":472.3246,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents VWAP of purchases of 17 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $27.525 to $28.405."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778206,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1048,"price":26.7259,"value":28008.7432,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents VWAP of purchases of 1,048 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $26.2587 to $27.1994."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778205,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":1770,"price":25.3209,"value":44817.993,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents VWAP of purchases of 1,770 shares of the Company's Common Stock on March 31, 2026 at prices ranging from $25.13 to $26.12."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778204,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:57.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":616,"price":24.6857,"value":15206.3912,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price (\"VWAP\") of purchases of 616 shares of common stock (\"Common Stock\"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the \"Company\") on March 31, 2026 at prices ranging from $23.91 to $24.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":146657,"source":{"system":"sec-edgar","filing":"0001104659-26-062605","document":"tm2614687-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062605/tm2614687-3_4seq1.xml","form_type":"4"}},{"id":778186,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":370,"price":27.68,"value":10241.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Represents sales of 370 shares of the Company's Common Stock on March 30, 2026 at $27.68 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778185,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"sale","planned":false,"acquired":false,"shares":518,"price":25.8501,"value":13390.3518,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Represents VWAP of sales of 518 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $25.13 to $26.0734."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778184,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":370,"price":27.68,"value":10241.6,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Represents purchases of 370 shares of the Company's Common Stock on March 30, 2026 at $27.68 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778183,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":1176,"price":26.7,"value":31399.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Represents VWAP of purchases of 1,176 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $26.50 to $26.90."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778182,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":4995,"price":25.99,"value":129820.05,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents VWAP of purchases of 4,995 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $25.50 to $26.48."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778181,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":2992,"price":25.0784,"value":75034.5728,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents VWAP of purchases of 2,992 shares of the Company's Common Stock on March 30, 2026 at prices ranging from $24.495 to $25.1856."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":145678,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778180,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":36,"price":27.369,"value":985.284,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents VWAP of sales of 36 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $27.2322 to $27.68."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778179,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"sale","planned":false,"acquired":false,"shares":469,"price":26.7652,"value":12552.8788,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents VWAP of sales of 469 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $26.21 to $26.95."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778178,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":294,"price":28.1301,"value":8270.2494,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents VWAP of purchases of 294 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $28.10 to $28.60."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778177,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":4384,"price":27.2826,"value":119606.9184,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents VWAP of purchases of 4,384 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $26.9750 to $27.68."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778176,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":10643,"price":26.2933,"value":279839.5919,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents VWAP of purchases of 10,643 shares of the Company's Common Stock on March 27, 2026 at prices ranging from $25.9197 to $26.88."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":142360,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778175,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":1274,"price":28.6882,"value":36548.7668,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents VWAP of sales of 1,274 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $28.07 to $28.7651."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778174,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":583,"price":26.8797,"value":15670.8651,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents VWAP of sales of 583 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $26.68 to $27.4650."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778173,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":1025,"price":29.9788,"value":30728.27,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents VWAP of purchases of 1,025 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $29.79 to $30.105."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778172,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":2601,"price":28.8539,"value":75048.9939,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents VWAP of purchases of 2,601 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $28.7072 to $29.51."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778171,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":1327,"price":27.9467,"value":37085.2709,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents VWAP of purchases of 1,327 shares of the Company's Common Stock on March 26, 2026 at prices ranging from $27.70 to $28.4163."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}},{"id":778170,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":47115,"kind":"organization","name":"MILLENNIUM MANAGEMENT LLC","position":1,"cik":"0001273087","reported_name":"MILLENNIUM MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47116,"kind":"organization","name":"ICS OPPORTUNITIES II LLC","position":2,"cik":"0001783647","reported_name":"ICS OPPORTUNITIES II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47117,"kind":"organization","name":"MILLENNIUM GROUP MANAGEMENT LLC","position":3,"cik":"0001446830","reported_name":"MILLENNIUM GROUP MANAGEMENT LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":47118,"kind":"person","name":"ENGLANDER ISRAEL A","position":4,"cik":"0001017456","reported_name":"ENGLANDER ISRAEL A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:22:04.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":778,"price":27.2267,"value":21182.3726,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price (\"VWAP\") of purchases of 778 shares of common stock (\"Common Stock\"), par value $0.0001 per share, of Sensei Biotherapeutics, Inc. (the \"Company\") on March 26, 2026 at prices ranging from $26.66 to $27.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting persons will provide full information regarding the number of shares purchased or sold by the reporting person at each separate price within each range represented by a VWAP disclosed herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In each case, the number of shares of the Company's Common Stock disclosed in column 5 is the number of shares of the Company's Common Stock beneficially owned by Millennium Management LLC at the conclusion of the transactions on the date disclosed in the corresponding entry in column 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The transactions in the Company's Common Stock reported herein were made by ICS Opportunities II LLC or other trading entities, in each case subject to voting control and investment discretion by Millennium Management LLC, Millennium Group Management LLC (the managing member of Millennium Management LLC) and Israel A. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). Each reporting person disclaims beneficial ownership of the shares of the Company's Common Stock disclosed herein except to the extent of such reporting person's pecuniary interest therein, if any."}],"balance_after":131370,"source":{"system":"sec-edgar","filing":"0001104659-26-062603","document":"tm2614687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000110465926062603/tm2614687-2_4seq1.xml","form_type":"4"}}]}